BIOCYTOGEN-B News

BIOCYTOGEN-B: ANNOUNCEMENT ON PRELIMINARY FINANCIAL DATA FOR THESIX MONTHS ENDED JUNE 30, 2024

Aug 7 04:30 ET

BIOCYTOGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024

Aug 6 06:50 ET

BIOCYTOGEN-B: VOLUNTARY ANNOUNCEMENTENTERS INTO OPTION AND LICENSE AGREEMENT WITH IDEAYAFOR POTENTIAL FIRST-IN-CLASS B7H3/PTK7 TOPO-I-PAYLOADBISPECIFIC ADC PROGRAM

Jul 31 05:30 ET

BIOCYTOGEN-B: VOLUNTARY ANNOUNCEMENTENTERS INTO MULTI-TARGET ANTIBODY AGREEMENT WITH SOTIO

Jul 16 07:30 ET

BIOCYTOGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024

Jul 3 05:42 ET

BIOCYTOGEN-B: VOLUNTARY ANNOUNCEMENT Biocytogen Secures U.S. Patent for RenLiteCommon Light Chain Mouse Platform

Jun 21 04:30 ET

BIOCYTOGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024

Jun 6 05:29 ET

BIOCYTOGEN-B: POLL RESULTS OF THE 2023 ANNUAL GENERAL MEETINGHELD ON MAY 28, 2024

May 28 09:13 ET

BIOCYTOGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024

May 7 06:25 ET

BIOCYTOGEN-B: FORM OF PROXY FOR THE USE AT THE 2023 ANNUAL GENERAL MEETING

Apr 25 05:41 ET

BIOCYTOGEN-B: NOTICE OF THE 2023 ANNUAL GENERAL MEETING

Apr 25 05:40 ET

BIOCYTOGEN-B: (1)2023 ANNUAL REPORT... (2)WORK REPORT OF BOARD (3)WORK REPORT OF SUPERVISORY COMMITTEE (4)FINAL ACCOUNTS REPORT (5)PROPOSED RE-APPOINTMENT OF AUDITOR (6)PROPOSED REMUNERATION OF DIRECTORS (7)PROPOSED REMUNERATION OF SUPERVISORS (8)PROPOSED PROFIT DISTRIB

Apr 25 05:39 ET

BIOCYTOGEN-B: 2023 Annual Report

Apr 25 05:38 ET

BIOCYTOGEN-B: VOLUNTARY ANNOUNCEMENT (1) UNUSUAL PRICE MOVEMENT; AND (2) SHARE PURCHASE BY TRUSTEE PURSUANT TO SHARE AWARD SCHEME

Apr 11 08:40 ET

BIOCYTOGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

Apr 3 05:45 ET

BIOCYTOGEN-B: ANNOUNCEMENT OF ANNUAL RESULTSFOR THE YEAR ENDED DECEMBER 31, 2023

Mar 27 06:05 ET

BIOCYTOGEN-B: DATE OF BOARD MEETING

Mar 15 04:33 ET

BIOCYTOGEN-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

Mar 6 03:39 ET

BIOCYTOGEN-B: ANNOUNCEMENT ON PRELIMINARY FINANCIAL DATA FORTHE YEAR ENDED DECEMBER 31, 2023

Feb 23 03:30 ET

BIOCYTOGEN-B: VOLUNTARY ANNOUNCEMENTBIOCYTOGEN AND GILEAD ENTER INTO A MULTI-TARGETANTIBODY COLLABORATION AGREEMENT

Feb 19 03:30 ET